PT - JOURNAL ARTICLE AU - Chakroborty, Sajal TI - H-MpoxNet: A Hybrid Deep Learning Framework for Mpox Detection from Image Data AID - 10.1101/2024.11.26.24318006 DP - 2024 Jan 01 TA - medRxiv PG - 2024.11.26.24318006 4099 - http://medrxiv.org/content/early/2024/11/29/2024.11.26.24318006.short 4100 - http://medrxiv.org/content/early/2024/11/29/2024.11.26.24318006.full AB - Infectious diseases can create significant global threats to public health and economic stability by creating pandemics. SARS-CoV-2 is a recent example. Early detection of infectious diseases is crucial to prevent global outbreaks. Mpox, a contagious viral disease first detected in humans in 1970, has experienced multiple outbreaks in recent decades, which emphasizes the development of tools for its early detection. In this paper, we develop a hybrid deep learning framework for Mpox detection. This framework allows us to construct hybrid deep learning models combining deep learning architectures as a feature extraction tool with Machine Learning classifiers and perform a comprehensive analysis of Mpox detection from image data. Our best-performing model consists of MobileNetV2 with LightGBM classifier, which achieves an accuracy of 91.49%, 91.87% weighted precision, 91.49% weighted recall, 91.51% weighted F1-score and Matthews Correlation Coefficient score of 0.83.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research didn't receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:https://www.kaggle.com/datasets/nafin59/monkeypox-skin-lesion-datasetI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at kaggle.com https://www.kaggle.com/datasets/nafin59/monkeypox-skin-lesion-dataset